Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-04 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
3,860 | $36.22 | $139,801 | 247,173 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,590 | $30.48 | $48,463 | 251,033 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
10,000 | $30.15 | $301,511 | 1,292,987 (Direct) |
View |
| 2025-02-05 Sale |
2025-02-07 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
3,520 | $40.69 | $143,229 | 423,998 (Direct) |
View |
| 2025-02-05 Sale |
2025-02-07 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
15,000 | $40.58 | $608,700 | 1,302,987 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 8:00 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
15,000 | $48.85 | $732,693 | 1,309,487 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-03 8:00 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
4,085 | $46.94 | $191,740 | 427,518 (Direct) |
View |
| 2024-12-12 Purchase |
2024-12-16 06:00 am |
Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director |
20,000 | $49.54 | $990,775 | 20,000 (Direct) |
View |
| 2024-12-11 Sale |
2024-12-13 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
4,540 | $48.76 | $221,363 | 431,603 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $46.07 | $307,057 | 260,798 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
15,000 | $46.58 | $698,654 | 1,324,487 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $59.12 | $394,041 | 267,463 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
15,000 | $59.22 | $888,320 | 1,339,487 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-04 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $56.26 | $374,954 | 274,128 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-04 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
40,000 | $56.23 | $2,249,307 | 1,354,487 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 8:03 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $47.56 | $316,969 | 280,793 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 8:02 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
40,000 | $47.62 | $1,904,841 | 1,394,487 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-23 8:05 pm |
Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer |
6,000 | $48.26 | $289,560 | 200,871 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-09 8:05 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
7,335 | $40.67 | $298,336 | 287,458 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-09 8:05 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
40,000 | $40.62 | $1,624,764 | 1,434,487 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-05 8:01 pm |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
15,000 | $37.26 | $558,900 | 1,474,487 (Direct) |
View |
| 2024-07-03 Sale |
2024-07-05 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
5,995 | $37.6 | $225,418 | 294,793 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Exercise |
2025-02-07 8:02 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
795 | $22.86 | 423,998 (Direct) |
View |
| 2025-02-05 Exercise |
2025-02-07 8:02 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
795 | $0 | 423,998 (Direct) |
View |
| 2025-01-31 Exercise |
2025-01-31 8:00 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
8,500 | $22.86 | 1,707,999 (Direct) |
View |
| 2025-01-31 Exercise |
2025-01-31 8:00 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
8,500 | $0 | 1,707,999 (Direct) |
View |
| 2025-01-02 Exercise |
2025-01-03 8:00 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,360 | $22.86 | 427,518 (Direct) |
View |
| 2025-01-02 Exercise |
2025-01-03 8:00 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,360 | $0 | 427,518 (Direct) |
View |
| 2024-12-11 Exercise |
2024-12-13 8:01 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,815 | $22.86 | 431,603 (Direct) |
View |
| 2024-12-11 Exercise |
2024-12-13 8:01 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,815 | $0 | 431,603 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 8:02 pm |
N/A 2034-12-09 |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
357,036 | $0 | 357,036 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 8:02 pm |
N/A 2034-12-09 |
Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer |
124,962 | $0 | 124,962 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 8:01 pm |
N/A 2034-12-09 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
124,962 | $0 | 124,962 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:12 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
10,370 | $0 | 10,370 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:05 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director |
10,370 | $0 | 10,370 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:04 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director |
8,112 | $0 | 8,112 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:03 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director |
10,370 | $0 | 10,370 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:02 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Shah Nimish P Director |
10,370 | $0 | 10,370 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:01 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director |
10,370 | $0 | 10,370 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:00 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director |
20,740 | $0 | 20,740 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 8:07 pm |
N/A 2034-05-28 |
Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director |
18,550 | $0 | 18,550 (Direct) |
View |
| 2024-03-28 Other |
2024-04-01 5:44 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
498,765 | $0 | 9,006,126 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:31 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
943,695 | $0 | 1,046,027 (Indirect) |
View |
| 2023-12-18 Option Award |
2023-12-20 8:01 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
175,345 | $0 | 175,345 (Direct) |
View |
| 2023-12-18 Option Award |
2023-12-20 8:00 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer |
175,345 | $0 | 175,345 (Direct) |
View |
| 2023-12-18 Option Award |
2023-12-20 8:00 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
398,512 | $0 | 398,512 (Direct) |
View |